The Expression of HDAC 1/2/3 in Breast Cancer and It’s Association with Molecular Typing and Clinical Index

周萍,王莉,王琼,黄一凡,文彬
DOI: https://doi.org/10.16252/j.cnki.issn1004-0501-2015.07.001
2015-01-01
Abstract:Objective To investigate the clinicopathological relationships between the expressions of HDAC1, HDAC2, HDAC3 and molecular subtypes in patients with breast invasive ductal carcinoma. Methods The protein expressions of ER, PR, HER2, Ki-67, HDAC1, HDAC2 and HDAC3 were immunohistochemically analyzed on paraffin imbedded tissues in 278 cases with breast invasive ductal carcinoma. Results HDAC1/2/3 significantly were over expressed in the subtype of luminal A, and HDAC3 nas over expressed in HER2 subtype. HDAC1 correlated significantly with ER, PR and Ki-67 expression, over expression of HDAC1 predicted better prognosis. Conclusion HDAC1/2/3 played significant roles in the development of different subtypes of breast cancer.
What problem does this paper attempt to address?